ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Enfortumab Biosimilar - Anti-Nectin-4 Antibody - Low endotoxin, Azide free (A323423)

Recombinant human monoclonal antibody to Nectin-4 for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Enfortumab Biosimilar - Anti-Nectin-4 Antibody - Low endotoxin, Azide free
Description
Recombinant human monoclonal antibody to Nectin-4.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 144.8 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
Ig superfamily receptor LNIR, LNIR, Nectin cell adhesion molecule 4, NECTIN4, Poliovirus receptor-related protein 4, PRR4
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Enfortumab Biosimilar - Anti-Nectin-4 Antibody - Low endotoxin, Azide free (A323423)? Please let us know so that we can list the citation on this page.

Alternative products to Enfortumab Biosimilar - Anti-Nectin-4 Antibody - Low endotoxin, Azide free (A323423)

Proteins predicted to interact with PVRL4

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.7% Relevancy Score
98.6% Relevancy Score
93.3% Relevancy Score
92.4% Relevancy Score
90.1% Relevancy Score
84.8% Relevancy Score
80.9% Relevancy Score
69.7% Relevancy Score
68.3% Relevancy Score